贵阳市中老年人群血脂异常知晓率、治疗率及控制率3年随访研究

doi:10.16150/j.1671-2870.2016.05.011

诊断学理论与实践 ›› 2016, Vol. 15 ›› Issue (05): 487-491.doi: 10.16150/j.1671-2870.2016.05.011

贵阳市中老年人群血脂异常知晓率、治疗率及控制率3年随访研究

张淼, 张颖, 时立新, 张巧, 彭年春, 胡颖

贵州医科大学附属医院内分泌代谢病科,贵州贵阳 550004

收稿日期:2016-07-22 出版日期:2016-10-25 发布日期:2022-07-27
通讯作者: 时立新 E-mail: slx1962@medmail.com.cn
基金资助:
贵州省省长资金临床应用课题专项研究（黔省专合字2012-100号）; 贵州省科技合作计划项目（黔科合LH字[2015]7413号）

Awareness, treatment and control of dyslipidemia in middle-aged and older population in Guiyang: A three-year follow-up study

ZHANG Miao, ZHANG Ying, SHI Lixin, ZHANG Qiao, PENG Nianchun, HU Ying

Department of Endocrinology and Metabolism, Affiliated Hospital of Guizhou Medical University, Guizhou Guiyang 550004, China

Received:2016-07-22 Online:2016-10-25 Published:2022-07-27

摘要/Abstract

摘要： 目的: 对贵阳市40岁以上血脂异常的常住中老年人群进行3年的随访研究,分析其血脂异常知晓率、治疗率和控制情况及其相关因素。方法: 于2011年随机抽取贵阳市城区≥40岁的6 872例血脂异常人群作为研究对象,进行问卷调查、体格检查及血糖、血脂测定,于2014年再次对上述人群进行3年后回访,分析该人群血脂异常的知晓率、治疗率、控制率及其相关因素。结果: 2011年基线血脂异常人群在2014年回访中血脂异常的知晓率、药物治疗率、控制达标率分别为29.9%、6.4%、17.2%,其中低高密度脂蛋白胆固醇血症、高低密度脂蛋白胆固醇血症、高总胆固醇血症、高三酰甘油血症控制达标率分别为76.7%、27.5%、19.9%、27.7%。分析显示,导致血脂异常未达标的相关因素包括女性、高餐后血糖、高舒张压、高体质量指数。结论: 贵阳市血脂异常老年人群中的血脂异常知晓率、降脂药物治疗率、控制达标率均较低。

关键词: 血脂异常, 知晓率, 治疗率, 控制率

Abstract: Objective: To study the status of awareness, treatment, control of dyslipidemia in people aged40years, over in Guiyang. Methods: A total of6,872adults aged40years, over with dyslipidemia in Guiyang were recruited randomly in2011, 2014. Baseline, follow-up clinical, laboratory data were collected through questionnaire survey, physical examination, blood glucose, lipid tests. The status of awareness, treatment, control of dyslipidemia, relative factors were analyzed. Results: Three years of follow up showed that the awareness, treatment, control rates of dyslipidemia among middle-aged, older adults with dyslipidemia were29.9%, 6.4%, 17.2%, respectively, the successful control rates of HDL cholesterol, LDL cholesterol, total cholesterol, triglyceride were76.7%, 27.5%, 19.9%, 27.7%, respectively. Factors related to unsuccessful control included female, postprandial blood glucose, diastolic blood pressure, BMI. Conclusions: The awareness, treatment, successful control rates of dyslipidemia in middle-aged, over adults with dyslipidemia in Guiyang are low, should pay more attention

Key words: Dyslipidemia, Awareness rate, Treatment rate, Control rate

中图分类号:

R589.2

张淼, 张颖, 时立新, 张巧, 彭年春, 胡颖. 贵阳市中老年人群血脂异常知晓率、治疗率及控制率3年随访研究[J]. 诊断学理论与实践, 2016, 15(05): 487-491.

ZHANG Miao, ZHANG Ying, SHI Lixin, ZHANG Qiao, PENG Nianchun, HU Ying. Awareness, treatment and control of dyslipidemia in middle-aged and older population in Guiyang: A three-year follow-up study[J]. Journal of Diagnostics Concepts & Practice, 2016, 15(05): 487-491.

参考文献

[1] Healy GN, Matthews CE, Dunstan DW, et al.Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06[J]. Eur Heart J,2011,32(5):590-597.
[2] McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries(the INTERHEART study): a case-control study[J]. Lancet,2008,372(9634):224-233.
[3] Farzadfar F, Finucane MM, Danaei G, et al.National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants[J]. Lancet,2011,377(9765):578-586.
[4] Kuklina EV, Yoon PW, Keenan NL.Trends in high le-vels of low-density lipoprotein cholesterol in the United States, 1999-2006[J]. JAMA,2009,302(19):2104-2110.
[5] Carroll MD, Lacher DA, Sorlie PD, et al.Trends in serum lipids and lipoproteins of adults, 1960-2002[J]. JAMA,2005,294(14):1773-1781.
[6] Downs JR, Clearfield M, Weis S, et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study[J]. JAMA,1998,279(20):1615-1622.
[7] Shepherd J, Cobbe SM, Ford I, et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group[J]. N Engl J Med,1995,333(20):1301-1307.
[8] 李剑虹, 王丽敏, 米生权, 等. 2010年我国成年人血脂异常知晓率和治疗率及控制率调查[J]. 中华预防医学杂志,2012,46(8):687-691.
[9] Ning G; Reaction Study Group.Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study[J]. J Diabetes,2012,4(2):172-173.
[10] 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志,2007,35(5):390-413.
[11] 张巧, 时立新, 彭年春, 等. 贵阳城区糖尿病、糖尿病前期流行病学调查及危险因素分析[J]. 中华内分泌代谢杂志,2013,29(2):144-147.
[12] 李剑虹,王丽敏,李镒冲,等.2010年我国成年人血脂异常流行特点[J]. 中华预防医学杂志,2012,46(5):414-418.
[13] Stamler J, Daviglus ML, Garside DB, et al.Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity[J]. JAMA,2000,284(3):311-318.
[14] LaRosa JC, He J, Vupputuri S. EEffect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials[J]. JAMA,1999,282(24):2340-2346.
[15] Lee YH, Lee SG, Lee MH, et al.Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg[J]. J Am Heart Assoc,2014,3(1):e000650.
[16] 孙永红, 刘娜. 中青年干部血脂异常知晓及治疗状况调查分析[J]. 心血管病防治知识(学术版),2012,11(2):8-9.
[17] Cai L, Zhang L, Liu A, et al.Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China[J]. J Atheroscler Thromb,2012,19(2):159-168.
[18] Upadhyay UD, Waddell EN, Young S, et al.Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004[J]. Prev Chronic Dis,2010,7(3):A61.
[19] He J, Gu D, Reynolds K, et al.Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[J]. Circulation,2004,110(4):405-411.
[20] 李鹏, 李勇, 郭志刚. 中国人群血脂流行病学研究25年回顾与展望[J]. 心血管病学进展,2007,28(5):776-780.

贵阳市中老年人群血脂异常知晓率、治疗率及控制率3年随访研究

Awareness, treatment and control of dyslipidemia in middle-aged and older population in Guiyang: A three-year follow-up study

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	王姗姗, 周莹霞, 胡利娟, 牛静雅, 王天歌, 李勉, 赵志云, 徐瑜, 陆洁莉, 徐敏, 毕宇芳, 倪衡如. 上海中年人群不同脂肪分布指标与血脂异常的相关性流行病学研究[J]. 诊断学理论与实践, 2019, 18(2): 177-182.
[2]	肖显超, 刘玉佳, 王刚, 孙成林, 赫广玉, 王桂侠,. 比较不同肥胖评价指标对脂代谢异常的预测能力[J]. 诊断学理论与实践, 2016, 15(04): 360-363.
[3]	木良善, 苏颋为, 姜蕾, 蒋怡然, 周薇薇, 王卫庆, 宁光,. 嗜铬细胞瘤患者血浆间甲肾上腺素类物质与血压及糖脂代谢的相关性研究[J]. 诊断学理论与实践, 2015, 14(04): 318-323.
[4]	李光庭, 丘创华, 曾伟杰, 欧超伟,. 普伐他汀对血脂异常患者血清脂联素的影响[J]. 诊断学理论与实践, 2008, 7(01): 77-79.
[5]	蒋利, 周林, 钟健, 闫振成, 倪银星, 陈静, 祝之明,. 糖脂代谢紊乱对女性代谢综合征患者左室结构与功能的影响[J]. 诊断学理论与实践, 2007, 6(02): 119-122.
[6]	李志艳,徐国宾,夏铁安. 北京市部分职业人员血脂水平及血脂异常流行情况[J]. 诊断学理论与实践, 2004, 3(05): 21-26.